Medical Science Liaison
PharmaEssentia U.S.A.
Medical Science Liaison
PharmaEssentia U.S.A.
Develops biologics for hematology, oncology, immunology
About PharmaEssentia:
It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity at PharmaEssentia. Join us, and let’s transform lives, together.
PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung.
Position Overview:
The primary responsibility of a Medical Science Liaison (MSL) is the exchange of medical information with health care professionals (HCPs) involved with the management of myeloproliferative neoplasms (MPNs). As a key member of the Medical Affairs Team, you will facilitate and develop the relationship with the medical/scientific community including physicians and medical centers, by communicating product-related information to investigators and institutions. In addition, you will liaise between the scientific community and PharmaEssentia to enhance the comprehension of scientific foundations and goals for approved, in-development and active company sponsored trials and/or investigator-sponsored research studies.
Key Responsibilities:
At PharmaEssentia, our goal is to treat as many people with cancer as possible. That means challenging the status quo with better science that leads to better lives. By joining our team, you will not only expand your own possibilities, but you will contribute to expanding options for people with cancer.
Develops biologics for hematology, oncology, immunology
PharmaEssentia USA Corporation develops and commercializes biologic medicines in hematology, oncology, and immunology as part of PharmaEssentia Corporation’s global biopharmaceutical program. Its therapies are biologics—medicines made from living organisms—designed to treat blood disorders, cancers, and immune-related diseases by targeting specific biological pathways. The company differentiates itself through its global footprint and sustained scientific focus, expanding operations across the U.S., Japan, China, and Korea and applying deep scientific expertise to bring new biologics to healthcare systems. The overarching goal is to grow its worldwide presence while delivering new biologic treatments to patients in need.
Explore more opportunities at PharmaEssentia U.S.A.